Form 4: Canopy Growth Director Willy Kruh Receives Significant RSU Grant

Canopy Growth Corp. Director Willy Kruh was granted 74,586 restricted stock units (RSUs) on June 3, 2025, as part of his compensation.

Summary

• Willy Kruh, a Director of Canopy Growth Corp. (CGC), acquired 74,586 common shares in the form of Restricted Stock Units (RSUs).
• The transaction occurred on June 3, 2025, with a reported acquisition price of $0, which is typical for RSU grants.
• Following this acquisition, Mr. Kruh's beneficial ownership in Canopy Growth Corp. stands at 83,858 common shares.
• These RSUs are scheduled to vest in four equal installments on June 30, 2025, September 29, 2025, December 31, 2025, and March 31, 2026.

Sentiment

Score: 7

Explanation: The filing reports a standard equity grant to a director, which is generally a positive sign of alignment between management/board and shareholders. It doesn't contain any negative news or unexpected events, hence a neutral to slightly positive score.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their interests with shareholders, as the value of the compensation is directly tied to the company's stock performance.
• An increase in beneficial ownership for Director Willy Kruh through this equity grant suggests continued commitment and confidence in the company's future performance.

Risks

• The ultimate value of the granted RSUs to Director Willy Kruh is contingent upon the future stock performance of Canopy Growth Corp., exposing the director to market risk until the RSUs vest and are converted to shares.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction, beyond the specified vesting schedule of the granted RSUs.

Industry Context

The grant of Restricted Stock Units (RSUs) to a director is a routine compensation event for publicly traded companies across various industries, including the cannabis sector where Canopy Growth operates. This practice aligns with standard corporate governance principles aimed at incentivizing long-term value creation and retaining key personnel.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to directors is a common practice in publicly traded companies across various sectors, including the cannabis industry.
• While specific compensation packages vary, the use of equity-based awards like RSUs is standard for aligning director interests with long-term shareholder value.
• Without specific compensation benchmarks for comparable companies like Tilray Brands (TLRY) or Cronos Group (CRON) at this exact date, a direct quantitative comparison of the grant size is not feasible from this document alone.
• However, the mechanism of granting RSUs at a $0 acquisition price, with a multi-installment vesting schedule, is consistent with typical industry compensation structures for non-executive directors.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns their interests with shareholders, as the value of the compensation is tied to the company's stock performance, potentially fostering long-term value creation.

Next Steps

• The granted RSUs will vest in four equal installments on June 30, 2025, September 29, 2025, December 31, 2025, and March 31, 2026.

Key Dates

Recommendation

Keywords

Canopy Growth Corp, CGC, Form 4, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Grant, Willy Kruh